Yanfeng Zhou

Yanfeng is the CMC director of Apeiron Therapeutics. He has over 15 years of experience in drug discovery and non-clinical development with a focus on CMC. Prior to joining Apeiron, he served as the R&D director at 2Y-Chem Co., LTD., where he made significant contributions and led several programs through the non-clinical development phase and into phase 1 clinical trials. Moreover, Yanfeng has developed and supported several IND and ANDA applications. Yanfeng obtained his master's degree in Pharmaceutical Chemistry from China Pharmaceutical University.